Catheter Precision(VTAK) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Catheter Precision, Inc. Reports Results of Operations for Second Quarter 2025 Revenue Increased 128% Year Over Year and 48% Sequentially Fort Mill, SC, AUGUST 11, 2025 – Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announced its results of operations for the three and six months ended June 30, 2025. Highlights of the second quarter include: About VIVO™ C ...